NO342258B1 - 2-amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-oner, fremgangsmåte for fremstilling derav og farmasøytiske preparater inneholdende slike - Google Patents

2-amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-oner, fremgangsmåte for fremstilling derav og farmasøytiske preparater inneholdende slike Download PDF

Info

Publication number
NO342258B1
NO342258B1 NO20082069A NO20082069A NO342258B1 NO 342258 B1 NO342258 B1 NO 342258B1 NO 20082069 A NO20082069 A NO 20082069A NO 20082069 A NO20082069 A NO 20082069A NO 342258 B1 NO342258 B1 NO 342258B1
Authority
NO
Norway
Prior art keywords
substituted
phenyl
methoxy
unsubstituted
pyridin
Prior art date
Application number
NO20082069A
Other languages
English (en)
Norwegian (no)
Other versions
NO20082069L (no
Inventor
Daniel J Poon
Teresa E Pick
Christopher Mcbride
Paul A Renhowe
Timothy D Machajewski
Cynthia M Shafer
William Antonios-Mccrea
Brandon M Doughan
Barry H Levine
Yi Xia
Maureen Mckenna
X Michael Wang
Kris Mendenhall
Yasheen Zhou
Baoqing Gong
Dan Gu
John Dolan
John Tulinsky
Kristin Brinner
Zhenhai Gao
Paul A Barsanti
Xiaodong Lin
Abran Costales
Alice Rico
Nathan Brammeier
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20082069L publication Critical patent/NO20082069L/no
Publication of NO342258B1 publication Critical patent/NO342258B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20082069A 2005-09-30 2008-04-30 2-amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-oner, fremgangsmåte for fremstilling derav og farmasøytiske preparater inneholdende slike NO342258B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72279605P 2005-09-30 2005-09-30
US83688606P 2006-08-09 2006-08-09
PCT/US2006/038181 WO2007041362A1 (en) 2005-09-30 2006-09-28 2-amino-7,8-dihydro-6h-pyrido[4,3-d] pyrimidin-5-ones

Publications (2)

Publication Number Publication Date
NO20082069L NO20082069L (no) 2008-06-09
NO342258B1 true NO342258B1 (no) 2018-04-30

Family

ID=37661234

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082069A NO342258B1 (no) 2005-09-30 2008-04-30 2-amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-oner, fremgangsmåte for fremstilling derav og farmasøytiske preparater inneholdende slike

Country Status (31)

Country Link
US (2) US7671059B2 (enExample)
EP (1) EP1928875B1 (enExample)
JP (2) JP5036002B2 (enExample)
KR (1) KR101311757B1 (enExample)
AR (1) AR058072A1 (enExample)
AT (1) ATE514694T1 (enExample)
AU (1) AU2006297124B2 (enExample)
BR (1) BRPI0616701A2 (enExample)
CA (1) CA2624253C (enExample)
CR (1) CR9846A (enExample)
CY (1) CY1112028T1 (enExample)
DK (1) DK1928875T3 (enExample)
EA (1) EA016152B1 (enExample)
EC (1) ECSP088324A (enExample)
GE (1) GEP20115231B (enExample)
HR (1) HRP20110655T1 (enExample)
IL (1) IL190446A0 (enExample)
JO (1) JO2783B1 (enExample)
MA (1) MA29885B1 (enExample)
ME (1) ME01952B (enExample)
MY (1) MY143604A (enExample)
NO (1) NO342258B1 (enExample)
NZ (1) NZ566914A (enExample)
PE (1) PE20070621A1 (enExample)
PL (1) PL1928875T3 (enExample)
PT (1) PT1928875E (enExample)
RS (1) RS51795B (enExample)
SM (1) SMP200800029B (enExample)
TN (1) TNSN08143A1 (enExample)
TW (1) TWI373471B (enExample)
WO (1) WO2007041362A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2007002994A1 (es) * 2006-10-19 2008-02-08 Wyeth Corp Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros.
CN101225083A (zh) * 2007-01-16 2008-07-23 北京摩力克科技有限公司 四氢喹唑啉酮类化合物及其用于制备治疗和预防病毒性疾病的药物的用途
GB2449293A (en) 2007-05-17 2008-11-19 Evotec Compounds having Hsp90 inhibitory activity
US8071766B2 (en) * 2008-02-01 2011-12-06 Takeda Pharmaceutical Company Limited HSP90 inhibitors
EP2334379A2 (en) 2008-09-26 2011-06-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Host cell kinases as targets for antiviral therapies against hcv infection
EP2370103B1 (en) * 2008-11-28 2016-03-23 Novartis AG Pharmaceutical combinations comprising an isoxazole derived hsp90-inhibitor and the her2 inhibitor trastuzumab
DK2370076T3 (en) * 2008-11-28 2017-04-03 Novartis Ag Pharmaceutical combination comprising an Hsp 90 inhibitor and an mTOR inhibitor
CN102227220A (zh) * 2008-11-28 2011-10-26 诺瓦提斯公司 用于治疗性治疗的Hsp90抑制剂
AR075180A1 (es) 2009-01-29 2011-03-16 Novartis Ag Formulaciones orales solidas de una pirido-pirimidinona
AR077405A1 (es) 2009-07-10 2011-08-24 Sanofi Aventis Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer
FR2949467B1 (fr) 2009-09-03 2011-11-25 Sanofi Aventis Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation
KR101690358B1 (ko) 2009-10-29 2017-01-09 제노스코 키나아제 억제제
WO2012104823A2 (en) 2011-02-04 2012-08-09 Novartis Ag Pyridopyrimidinone compounds in the treatment of neurodegenerative diseases
EP2766015A1 (en) 2011-10-14 2014-08-20 Novartis AG 2-carboxamide cycloamino urea derivatives in combination with hsp90 inhibitors for the treatment of proliferative diseases
ITTO20111013A1 (it) 2011-11-03 2013-05-04 Dac Srl Composti farmaceutici
CN103664938A (zh) * 2012-09-12 2014-03-26 山东亨利医药科技有限责任公司 含有嘧啶并环的syk抑制剂
RU2015121424A (ru) 2012-11-07 2016-12-27 Новартис Аг Комбинированная терапия
US9677907B2 (en) * 2013-03-14 2017-06-13 Itron Inc Intelligent receptacle
GB201306610D0 (en) * 2013-04-11 2013-05-29 Almac Discovery Ltd Pharmaceutical compounds
KR101767859B1 (ko) * 2013-09-30 2017-08-11 다이호야쿠힌고교 가부시키가이샤 아자 2 고리형 화합물을 사용한 암 병용 요법
JP2017525734A (ja) * 2014-09-02 2017-09-07 ピエール、ファーブル、メディカマン 癌の治療において有用なイソキノリノン誘導体
KR20160035411A (ko) * 2014-09-23 2016-03-31 주식회사 오스코텍 LRRK2 (Leucine Rich Repeat Kinase 2) 키나제 억제제로서의 피리도피리미딘 유도체 화합물
KR101653560B1 (ko) * 2016-02-02 2016-09-12 한국화학연구원 신규한 화합물 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 함유하는 인플루엔자 바이러스 감염으로 인한 질환의 예방 또는 치료용 약학적 조성물
RU2629599C1 (ru) * 2016-09-28 2017-08-30 Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" (ГБУЗ МО МОНИКИ им. М.Ф. Владимирского) Способ химиолучевого лечения опухолей прямой кишки и анального канала
JP7229158B2 (ja) 2017-06-09 2023-02-27 中外製薬株式会社 Ｎ－置換アミノ酸を含むペプチドの合成方法
US20230295108A1 (en) * 2020-06-26 2023-09-21 Nihon Nohyaku Co., Ltd. Aryltetrahydropyridine derivative or salt thereof, insecticidal agent containing the compound, and method of use thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0188094A2 (en) * 1984-12-14 1986-07-23 Mitsui Petrochemical Industries, Ltd. Quinazoline derivatives and antihypertensive preparations containing same as effective components

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6165873A (ja) * 1984-09-07 1986-04-04 Mitsui Petrochem Ind Ltd ２−ピペラジノピリミジン誘導体
MA21177A1 (fr) * 1987-02-11 1988-10-01 May & Baker Ltd Diones cycliques.
KR100639772B1 (ko) * 2001-02-12 2006-10-30 에프. 호프만-라 로슈 아게 6-치환된 피리도-피리미딘
DE102004018198A1 (de) 2004-04-15 2005-11-03 Merck Patent Gmbh Sulfonamide
EP2332527A3 (en) 2004-10-20 2011-11-16 Resverlogix Corp. Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases
WO2006074293A2 (en) 2005-01-07 2006-07-13 President And Fellows Of Harvard College Bicyclic dihydropyrimidines as eg5 inhibitors
US20070027150A1 (en) 2005-04-14 2007-02-01 Bellamacina Cornelia R 2-Amino-quinazolin-5-ones

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0188094A2 (en) * 1984-12-14 1986-07-23 Mitsui Petrochemical Industries, Ltd. Quinazoline derivatives and antihypertensive preparations containing same as effective components

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ASHTON, M. J. ET AL. Synthesis of 6-aryl-4-hydroxypiperidin-2-ones and a possible application. Heterocycle. 1989, vol, 28, nr, 2m s. 1015-1035., Dated: 01.01.0001 *

Also Published As

Publication number Publication date
GEP20115231B (en) 2011-06-10
AU2006297124A1 (en) 2007-04-12
AR058072A1 (es) 2008-01-23
MA29885B1 (fr) 2008-10-03
KR101311757B1 (ko) 2013-09-26
EA016152B1 (ru) 2012-02-28
DK1928875T3 (da) 2011-10-03
CY1112028T1 (el) 2015-11-04
SMAP200800029A (it) 2008-05-07
ECSP088324A (es) 2008-04-28
US20070123546A1 (en) 2007-05-31
ATE514694T1 (de) 2011-07-15
CR9846A (es) 2008-08-01
MY143604A (en) 2011-06-15
CA2624253A1 (en) 2007-04-12
HRP20110655T1 (hr) 2011-10-31
BRPI0616701A2 (pt) 2011-06-28
JP2009510108A (ja) 2009-03-12
ME01952B (en) 2011-12-31
EP1928875A1 (en) 2008-06-11
JP5036002B2 (ja) 2012-09-26
PT1928875E (pt) 2011-09-06
RS51795B (sr) 2011-12-31
JP2012158611A (ja) 2012-08-23
EA200800992A1 (ru) 2008-10-30
JO2783B1 (en) 2014-03-15
EP1928875B1 (en) 2011-06-29
WO2007041362A1 (en) 2007-04-12
TWI373471B (en) 2012-10-01
NO20082069L (no) 2008-06-09
PE20070621A1 (es) 2007-09-06
IL190446A0 (en) 2008-11-03
NZ566914A (en) 2011-09-30
KR20080057318A (ko) 2008-06-24
CA2624253C (en) 2015-06-16
PL1928875T3 (pl) 2011-11-30
AU2006297124B2 (en) 2011-12-08
TW200728304A (en) 2007-08-01
US20100004237A1 (en) 2010-01-07
TNSN08143A1 (en) 2009-07-14
SMP200800029B (it) 2008-05-07
HK1118823A1 (en) 2009-02-20
US7671059B2 (en) 2010-03-02

Similar Documents

Publication Publication Date Title
NO342258B1 (no) 2-amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-oner, fremgangsmåte for fremstilling derav og farmasøytiske preparater inneholdende slike
RU2681209C2 (ru) Модуляторы серин-треонинпротеинкиназ и parp
US7709488B2 (en) Imidazopyridine-derivatives as inducible no-synthase inhibitors
JP2007518822A (ja) 抗癌剤としてのテトラヒドロカルボリン化合物
JP2005516053A (ja) 縮合複素環式化合物
KR20080006614A (ko) 증식 질환의 치료에 유용한 ｈｓｐ90 억제제인2-아미노-퀴나졸린-5-온
CN101616667A (zh) 可用作激酶抑制剂的杂环酰胺化合物
CN100408576C (zh) 取代的3-氰基-[1.7],[1.5]和[1.8]-二氮杂萘酪氨酸激酶抑制剂
KR101599157B1 (ko) Crth₂ 수용체 조절제로서의 시클로알킬-융합된 테트라히드로퀴놀린
CN101287734B (zh) 2-氨基-7,8-二氢-6H-吡啶并[4,3-d]嘧啶-5-酮
CN115785074A (zh) Parp7抑制剂及其用途
EP3098222B1 (en) Fused acridine derivative and pharmaceutical composition, preparation method and use thereof
ES2369707T3 (es) 2-amino-7,8-dihidro-6h-pirido(4,3-d)pirimidin-5-onas, procedimiento para su preparación y composiciones farmacéuticas que contienen las mismas.
HK1118823B (en) 2-amino-7,8-dihydro-6h-pyrido(4,3-d)pyrimidin-5-ones, process for their preparation and pharmaceutical compositions containing the same
HK1123801A (zh) 2-氨基-7，8-二氢-6h-吡啶并[4，3-d]嘧啶-5-酮
HK40083035A (en) Parp7 inhibitor and use thereof
CN118307518A (zh) 多环类parp选择性抑制剂
CN111065635A (zh) 作为mth1抑制剂的新型嘧啶衍生物
HK1096549B (en) Imidazopyridine-derivatives as inducible no-synthase inhibitors
HK1122275A (en) 2-amino-quinazolin-5-ones as hsp90 inhibitors useful in treating proliferation diseases

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees